Asgard Therapeutics (ASGD) Appoints Wolfram Brugger as CMO
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowAsgard Therapeutics (ASGD) announced the appointment of Wolfram Brugger as chief medical officer. This change is expected to enhance the company’s clinical development capabilities. Brugger brings extensive experience in medical leadership, having previously held senior roles in other biotech firms. This move may improve stakeholder confidence and strategic direction within the company, reflecting on future growth potential.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
US Proposes Expansion of Curbs on Chinese Biotech and Tech Investments
Oct 24
Zymeworks (ZYME) Reports Trial Results for Ovarian Cancer Drug ZW191
Oct 24
Acadia Pharmaceuticals Names Interim Consultant for R&D Head Retirement
Oct 23
AbbVie (ABBV) FDA Approves Skyrizi Subcutaneous Induction Regimen
Oct 23